Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Spain: Treatment for hypertension, male
Treatment for hypertension, male over time
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
- Spain
How they compare
Spain currently reports 51.0% against 31.0% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 20.0%.
That makes Spain's figure about 1.6 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.
Across all 30 years both countries report, Spain has been ahead every year.
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 29th and Spain ranks 29th of 43 groups.
Spain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) | Spain | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 17.1% | 28.6% | 11.5% | Spain |
| 2000s | 23.8% | 38.1% | 14.3% | Spain |
| 2010s | 29.8% | 48.0% | 18.2% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment for hypertension, male, Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) or Spain?
- Spain, at 51.0% against 31.0% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2019.
- What is the difference in treatment for hypertension, male between Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Spain?
- 20.0%, with Spain ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Spain?
- 30 years are reported by both, from 1990 to 2019.
- How do Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Spain rank globally for treatment for hypertension, male?
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 29th and Spain ranks 29th of 43 groups.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.